Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody: associated vasculitis-a meta-analysis.

Kentaro Kuzuya Takayoshi MoritaAtsushi Kumanogoh

Published in: RMD open (2021)

We found no difference between the therapeutic efficacy of MMF and that of CYC in patients with AAV. MMF may be an alternative remission induction therapy in patients with non-life-threatening AAV.

Keyphrases

disease activity
gene therapy
ulcerative colitis
stem cells
rheumatoid arthritis
mesenchymal stem cells
systemic lupus erythematosus